News
New HHS contract reviews are delaying care and filling of vacancies, IHS insiders tell Stat News. Meanwhile, KFF Health News dives into rehabilitation hospitals.
Kenvue’s board of directors are considering ‘a broad range of potential alternatives’ and are hunting for a permanent ...
“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...
PARIS – L’Oréal Paris, Neutrogena, Nivea Q10 and Eucerin – from L’Oréal, Kenvue and Beiersdorf – are among brands starting to ...
Findings from YipitData show that TikTok Shop and Target are neck-and-neck by fragrance sales; Kayali is number one at ...
Perry is a current Kenvue director and seasoned consumer products and brand strategist with more than 30 years of experience.
Band-Aid and Tylenol maker Kenvue has fired its CEO Thibaut Mongon, the consumer health company said on Monday, laying what ...
Kenvue has five brands that generate over $1 billion in sales—Johnson’s, Neutrogena, Listerine, Tylenol, and Aveeno—as well as a number of brands that generate over $400 million in sales: Nicorette, ...
Kenvue appoints Kirk Perry as interim CEO after Thibaut Mongon's exit and launches strategic review to simplify operations.
21h
Investor's Business Daily on MSNKenvue Reverses Premarket Gains After Tylenol-Maker Unveils New CEO, Strategic ReviewKenvue stock reversed lower Monday after the company — known for brands like Tylenol — announced a new CEO and strategic ...
Current Kenvue Director, Kirk Perry, is named Interim CEO, effective immediately. Kenvue Board of Directors appointed a new ...
Private equity firm Cerberus and billionaire investor Dean Metropoulos teamed up in an unsuccessful bid for WK Kellogg, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results